Journal
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
Volume 121, Issue 5, Pages 1003-1007Publisher
ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2021.12.028
Keywords
COVID-19; mRNA vaccine; Pityriasis rosea
Categories
Ask authors/readers for more resources
In this case report, cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination are described. During the COVID-19 pandemic, PR or PR-like eruptions related to COVID-19 infection or vaccination have been rarely reported.
Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result from medications or vaccinations. Previously, PR-like eruptions had been noted following vaccination for influenza or other vaccines. During this pandemic, acute COVID-19 infection has been related to PR or PR-like eruptions in several cases. Various COVID-19 vaccines associated with PR-like eruptions were rarely reported. Herein, we report a case of cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination. Copyright (c) 2022, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available